TP53 and neoplasm: Consistently, HFD did not affect tumor incidence in mice with Sirt3 deletion (p53+/−: HFD vs. ctrl p < 0.0001/Sirt3−/−; p53+/−: HFD vs. ctrl p = 0.6).